-
ABPI Website
-
Building a stronger reputation in the UK
-
Disclosure UK
- Methodological notes by company and year
Methodological notes by company and year
Methodological Notes by Year / Company
Every company disclosing data on Disclosure UK about healthcare professionals (HCPs), other relevant decision makers (ORDMs), and healthcare organisations (HCOs) has provided a Methodological Note which explains how they compiled their data. Please ensure that you consider these notes when you are exploring the data.
To download a full HCP, ORDM and HCO dataset for each year, please visit the Disclosure UK search.
|
A. MENARINI |
2024 2023 2022 |
ABBVIE |
2024 2023 2022 |
|
|
ACCORD |
2024 2023 2022 |
ADVANZ PHARMA | - - 2022 |
|
| ADVANZ UK & IRE | 2024 2023 2022 |
AGB |
2024 2023 - |
|
|
AGUETTANT |
2024 2023 2022 |
ALEXION |
2024 2023 2022 |
|
|
ALFASIGMA |
2024 - - |
ALIMERA SCIENCES |
2024 2023 2022 |
|
|
ALK-ABELLO |
2024 2023 2022 |
ALLERGAN |
- - 2022 |
|
|
ALLIANCE |
2024 2023 2022 |
ALMIRALL |
2024 2023 2022 |
|
|
ALNYLAM |
2024 2023 2022 |
ALTURIX |
2024 2023 2022 |
|
|
AMARIN |
2024 2023 2022 |
AMGEN |
2024 2023 2022 |
|
|
AMICUS THERAPUTICS |
2024 2023 2022 |
AMRYT |
- 2023 2022 |
|
|
ANGELINI |
2024 2023 2022 |
ASCENDIS |
2024 - - |
|
|
ASPEN |
2024 - - |
ASTELLAS |
2024 2023 2022 |
|
|
ASTRAZENECA |
2024 2023 2022 |
ATNAHS |
2024 2023 2022 |
|
|
BAUSCH & LOMB |
2024 2023 2022 |
BAXTER HEALTHCARE |
2024 2023 2022 |
|
|
BAYER |
2024 2023 2022 |
BESINS HEALTHCARE |
2024 2023 2022 |
|
|
BIAL |
2024 2023 2022 |
BIO PRODUCTS LABORATORY |
2024 2023 2022 |
|
|
BIOCRYST |
2024 2023 2022 |
BIOGEN IDEC |
2024 2023 2022 |
|
|
BIOMARIN EUROPE |
2024 2023 2022 |
BIOPROJET |
2024 2023 2022 |
|
|
BLUE EARTH DIAGNOSTICS |
2024 2023 2022 |
BOEHRINGER INGELHEIM |
2024 2023 2022 |
|
|
BRACCO |
2024 2023 2022 |
BRISTOL-MYERS SQUIBB |
2024 2023 2022 |
|
|
BRITANNIA |
2024 2023 2022 |
CAMURUS |
2024 2023 2022 |
|
|
CELLTRION HEALTHCARE |
2024 2023 2022 |
CHIESI |
2024 2023 2022 |
|
|
CHUGAI |
2024 2023 2022 |
CIPLA |
2024 2023 2022 |
|
|
CLINUVEL |
2024 2023 2022 |
CNX THERAPEUTICS |
2024 - 2022 |
|
|
CONSILIENT HEALTH |
2024 2023 2022 |
CROMA |
2024 2023 2022 |
|
|
CSL BEHRING |
2024 2023 2022 |
DAIICHI SANKYO |
2024 2023 2022 |
|
|
DERMAL LABORATORIES |
2024 2023 2022 |
DIURNAL |
2024 2023 2022 |
|
|
DR FALK |
2024 2023 2022 |
EISAI |
2024 2023 2022 |
|
|
ELI LILLY |
2024 2023 2022 |
ESTEVE |
2024 - - |
|
|
ETHYPHARM GROUP |
2024 2023 2022 |
EVER |
2024 2023 2022 |
|
|
EXELTIS |
2024 2023 2022 |
FERRING |
2024 2023 2022 |
|
|
FLYNN |
2024 2023 2022 |
FRESENIUS MEDICAL CARE |
2024 2023 2022 |
|
|
FRESENIUS KABI |
2024 2023 2022 |
GALAPAGOS BIOTECH |
- 2023 2022 |
|
|
GALEN |
2024 2023 2022 |
GE HEALTHCARE |
2024 2023 2022 |
|
|
GEDEON RICHTER |
2024 2023 2022 |
GILEAD |
2024 2023 2022 |
|
|
GLAXOSMITHKLINE |
2024 2023 2022 |
GRUNENTHAL |
2024 2023 2022 |
|
|
GUERBET |
2024 2023 2022 |
HRA |
2024 2023 2022 |
|
IBSA |
2024 2023 - |
IDORSIA |
2024 2023 2022 |
|
|
IMMEDICA |
2024 2023 2022 |
INCYTE | 2024 - - |
|
|
INDIVIOR |
2024 2023 2022 |
INTERCEPT |
- - 2022 |
|
|
IPSEN |
2024 2023 2022 |
IQVIA IES |
2024 2023 2022 |
|
|
JANSSEN-CILAG (J&J CO) |
2024 - - |
JANSSEN-CILAG |
- 2023 2022 |
|
|
JAZZ |
2024 2023 2022 |
KORA |
2024 2023 2022 |
|
|
L.D. COLLINS |
2024 2023 2022 |
LEADIANT BIOSCIENCES |
2024 2023 2022 |
|
|
LEO |
2024 2023 2022 |
LUNDBECK |
2024 2023 2022 |
|
|
LUPIN |
2024 2023 2022 |
LUYE |
2024 - - |
|
MEDICE |
2024 2023 2022 |
MENARINI STEMLINE |
2024 2023 - |
|
|
MERCK SERONO |
2024 2023 2022 |
MERCK SHARP & DOHME |
2024 2023 2022 |
|
|
MERZ |
2024 2023 2022 |
MITSUBISHI TANABE |
2024 2023 2022 |
|
| MODERNA | 2024 2023 2022 |
MUNDIBIOPHARMA |
- - 2022 |
|
|
MUNDIPHARMA MEDICAL |
2024 2023 2022 |
MUNDIPHARMA RESEARCH |
2024 2023 2022 |
|
|
NAPP |
2024 2023 2022 |
NEON HEALTHCARE | 2024 2023 2022 |
|
|
NEURAXPHARM |
2024 2023 2022 |
NORGINE |
2024 2023 2022 |
|
|
NOVARTIS |
2024 2023 2022 |
NOVAVAX |
2024 2023 - |
|
|
NOVO NORDISK |
2024 2023 2022 |
OCTAPHARMA |
2024 2023 2022 |
|
|
ORGANON |
2024 2023 2022 |
ORION |
2024 2023 2022 |
|
|
ORPHALAN |
2024 2023 2022 |
OTSUKA |
2024 2023 2022 |
|
|
OUTLOOK |
2024 - - |
PACIRA BIOSCIENCES | 2024 2023 2022 |
|
|
PAION |
2024 2023 2022 |
PARI MEDICAL |
2024 2023 2022 |
|
|
PFIZER |
2024 2023 2022 |
PIRAMAL CRITICAL CARE |
2024 - - |
|
|
PHARMAMAR |
- 2023 2022 |
PHARMASURE |
- - 2022 |
|
|
PHARMA NORD |
2024 2023 - |
PIERRE FABRE |
2024 2023 2022 |
|
|
PROFILE |
- - 2022 |
PROVECA |
2024 2023 2022 |
|
|
PROVEPHARM |
2024 - - |
PTC THERAPEUTICS |
2024 2023 2022 |
|
RECKITT |
2024 2023 2022 |
RECORDATI UK | 2024 - - |
|
|
RECORDATI |
2024 2023 2022 |
RECORDATI RARE DISEASES |
2024 2023 2022 |
|
|
REGENERON |
2024 2023 2022 |
RHYTHM |
2024 2023 - |
|
|
ROCHE |
2024 2023 2022 |
ROSEMONT |
2024 2023 2022 |
|
|
SAMSUNG BIOEPIS |
2024 2023 - |
SANOFI AVENTIS |
2024 2023 2022 |
|
|
SANTEN |
2024 2023 2022 |
SANTHERA |
2024 - - |
|
|
SEQIRUS |
2024 2023 2022 |
SERVIER |
2024 2023 2022 |
|
|
SHIONOGI BV |
2024 2023 2022 |
SIFI |
2024 2023 2022 |
|
|
SOBI |
2024 2023 2022 |
STALLERGENES GREER |
2024 - - |
|
|
STD PRODUCTS |
- 2023 - |
STIRLING ANGLIAN |
2024 2023 2022 |
|
|
SUN |
2024 2023 - |
SYNER-MED |
2024 2023 2022 |
|
|
SYRI |
- 2023 2022 |
TAKEDA |
2024 2023 2022 |
|
|
TETRIS |
2024 - 2022 |
TEVA |
2024 2023 2022 |
|
|
THEA |
2024 2023 2022 |
THERAMEX |
2024 - - |
|
|
THERATECHNOLOGIES |
- - 2022 |
TILLOTTS |
2024 2023 2022 |
|
|
UCB |
2024 2023 2022 |
VALNEVA |
2024 2023 2022 |
|
|
VERITON |
2024 2023 2022 |
VIFOR GROUP |
2024 2023 2022 |
|
|
VISUFARMA |
2024 2023 - |
ZAMBON |
2024 2023 2022 |
Last modified: 27 June 2025
Last reviewed: 27 June 2025